Veterinary Medicines

Anthelmin 230 mg/20 mg film-coated tablets for cats

Authorised
  • Praziquantel
  • Pyrantel embonate
Download as PDF

Product identification

Medicine name:
Anthelmin 230 mg/20 mg film-coated tablets for cats
Anthelmin 230 mg/20 mg Filmtabletten für Katzen
Active substance:
  • Praziquantel
  • Pyrantel embonate
Target species:
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Praziquantel
    20.00
    milligram(s)
    /
    1.00
    Tablet
  • Pyrantel embonate
    230.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Film-coated tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AA51
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Austria
Package description:
  • (ID7) 100 Film-coated tablet: unspecified outer container with 10 Blister (oriented polyamide foil; aluminium; polyvinyl chloride) each with 10 Film-coated tablet, closed with Foil (aluminium)
  • (ID6) 50 Film-coated tablet: unspecified outer container with 5 Blister (oriented polyamide foil; aluminium; polyvinyl chloride) each with 10 Film-coated tablet, closed with Foil (aluminium)
  • (ID5) 30 Film-coated tablet: unspecified outer container with 3 Blister (oriented polyamide foil; aluminium; polyvinyl chloride) each with 10 Film-coated tablet, closed with Foil (aluminium)
  • (ID4) 10 Film-coated tablet: unspecified outer container with 1 Blister (oriented polyamide foil; aluminium; polyvinyl chloride) with 10 Film-coated tablet, closed with Foil (aluminium)
  • (ID2) 4 Film-coated tablet: unspecified outer container with 2 Blister (oriented polyamide foil; aluminium; polyvinyl chloride) each with 2 Film-coated tablet, closed with Foil (aluminium)
  • (ID1) 2 Film-coated tablet: unspecified outer container with 1 Blister (oriented polyamide foil; aluminium; polyvinyl chloride) with 2 Film-coated tablet, closed with Foil (aluminium)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • KRKA tovarna zdravil d.d. Novo mesto
  • TAD Pharma GmbH
  • Krka-Farma d.o.o.
  • Krka-Farma d.o.o.
Responsible authority:
  • Austrian Agency For Health And Food Safety
Authorisation number:
  • 837553
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0160/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Czechia
  • Estonia
  • Finland
  • France
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 27/01/2026
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 25/04/2025
Updated on: 16/07/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 25/04/2025
Updated on: 16/07/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 25/04/2025
Updated on: 16/07/2025
Download

2402275-paren-20191028.pdf

English (PDF)
Published on: 27/01/2026
Download